Home 
Sitemap
Sitemap
Sitemap
Main Menu
- Home
- About AMS
- Mission and Vision
- AMS Executive and Council
- Education and Research Sub Committee
- Education and Research Fund
- AMS Young Investigator's Award Winners 2009
- Awards
- Membership Application
- Member News
- Memorandum of Association
- Role Descriptions AMS Council
- The AMS Website
- Document on Conflict of Interest
- Accreditation
- Code of Ethics
- Privacy Statement
- Consumers
- Book Reviews
- Cochrane Reviews
- Exercise benefit small for osteoporosis
- Ginkgo biloba for intermittent claudication
- Oral Contraceptives for functional ovarian cysts
- Steroidal Contraceptives: effect on bone fractures in women
- Testosterone for peri- and post-menopausal women
- Spironolactone versus placebo or in combination with steroids for hirsuitism and/or acne
- Selective serotonin reuptake inhibitors for premenstrual syndrome
- Progesterone or progesterone releasing IUD systems for heavy menstrual bleeding
- Progesterone for premenstrual syndrome
- Phytoestrogens for vasomotor symptoms
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
- Antifibrinolytics for heavy menstrual bleeding
- Cyclical progestogens for heavy menstrual bleeding
- Exercise for vasomotor symptoms
- Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding
- Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
- Local oestrogen for vaginal atrophy in postmenopausal women
- Long term hormone therapy in perimenopausal and postmenopausal women
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding
- Oestrogen therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
- Oral contraceptive pills for heavy menstrual bleeding
- Oral contraceptives containing drospirenone for premenstrual syndrome
- Information Sheets
- AMS Guide to Equivalent HRT Doses
- Menopause - a management algorithm
- Low Libido and Testosterone Therapy
- What is menopause?
- Glossary of Terms
- Vaginal Atrophy after Breast Cancer
- Vaginal Atrophy - a Change with Menopause
- Coping With Menopause - Depression
- Menopause – Oestrogen Only Therapy
- Contraception For Women Approaching Menopause
- Menopause and osteoporosis
- The AMS Practitioners Guidelines for Oestradiol (E2) Implants
- WHI Study - Risks and Benefits graphs of HT/HRT
- The Role of SERMS after Menopause
- Sleep Disturbance and the Menopause
- NonHormonal Treatments for Menopausal Symptoms
- Bioidentical Hormones for Menopausal Symptoms
- Menopause and Body Changes
- Healthy Ageing and Lifestyle
- Early Menopause due to Chemotherapy
- Tibolone For Post-Menopausal Women
- Menopausal Treatments and the Risk of Blood Clots
- Treating the Menopause – the Concept of Risk and Benefit
- Early Menopause Due to Premature and Unexpected Ovarian Failure
- Menopause – Combined (Hormone Replacement Therapy)
- Diagnosing Menopause
- Position Statements
- Menopause and Heart Disease
- AMS - US Endocrine Society Scientific Statement
- RACGP Clinical Guideline for the Prevention and Treatment of Osteoporosis in Postmenopausal women and older men
- Estrogen & Progestogen use in Postmenopausal Women
- NAMS Position on Midlife Osteoporosis
- Ovarian Cancer Screening
- Aging, Menopause, Cardiovascular Disease & HRT
- IMS: HRT in the early menopause
- HRT & Breast Cancer
- Estrogen and progestogen use in postmenopausal women: July 2008
- HRT in the early menopause:
- IMS updated recommendations on postmenopausal hormone therapy
- Scientific Definitions for Menopause Related Terminology
- Resources
- Self Assessment Tools
- Video - Menopause: Evidence-based answers
- Find an AMS Doctor
- Health Professionals
- Book Reviews
- Cochrane Reviews
- Exercise benefit small for osteoporosis
- Ginkgo biloba for intermittent claudication
- Oral Contraceptives for functional ovarian cysts
- Steroidal Contraceptives: effect on bone fractures in women
- Testosterone for peri- and post-menopausal women
- Spironolactone versus placebo or in combination with steroids for hirsuitism and/or acne
- Selective serotonin reuptake inhibitors for premenstrual syndrome
- Progesterone or progesterone releasing IUD systems for heavy menstrual bleeding
- Progesterone for premenstrual syndrome
- Phytoestrogens for vasomotor symptoms
- Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes
- Antifibrinolytics for heavy menstrual bleeding
- Cyclical progestogens for heavy menstrual bleeding
- Exercise for vasomotor symptoms
- Hormone replacement therapy in postmenopausal women: endometrial hyperplasia and irregular bleeding
- Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women
- Local oestrogen for vaginal atrophy in postmenopausal women
- Long term hormone therapy in perimenopausal and postmenopausal women
- Nonsteroidal anti-inflammatory drugs for heavy menstrual bleeding
- Oestrogen therapy for peri-menopausal and post-menopausal women: weight and body fat distribution
- Oral contraceptive pills for heavy menstrual bleeding
- Oral contraceptives containing drospirenone for premenstrual syndrome
- Education
- Position Statements
- Menopause and Heart Disease
- AMS - US Endocrine Society Scientific Statement
- RACGP Clinical Guideline for the Prevention and Treatment of Osteoporosis in Postmenopausal women and older men
- Estrogen & Progestogen use in Postmenopausal Women
- NAMS Position on Midlife Osteoporosis
- Ovarian Cancer Screening
- Aging, Menopause, Cardiovascular Disease & HRT
- IMS: HRT in the early menopause
- HRT & Breast Cancer
- Estrogen and progestogen use in postmenopausal women: July 2008
- HRT in the early menopause:
- IMS updated recommendations on postmenopausal hormone therapy
- Scientific Definitions for Menopause Related Terminology
- Information Sheets
- AMS Guide to Equivalent HRT Doses
- Menopause - a management algorithm
- Low Libido and Testosterone Therapy
- What is menopause?
- Glossary of Terms
- Vaginal Atrophy after Breast Cancer
- Vaginal Atrophy - a Change with Menopause
- Coping With Menopause - Depression
- Menopause – Oestrogen Only Therapy
- Contraception For Women Approaching Menopause
- Menopause and osteoporosis
- The AMS Practitioners Guidelines for Oestradiol (E2) Implants
- WHI Study - Risks and Benefits graphs of HT/HRT
- The Role of SERMS after Menopause
- Sleep Disturbance and the Menopause
- NonHormonal Treatments for Menopausal Symptoms
- Bioidentical Hormones for Menopausal Symptoms
- Menopause and Body Changes
- Healthy Ageing and Lifestyle
- Early Menopause due to Chemotherapy
- Tibolone For Post-Menopausal Women
- Menopausal Treatments and the Risk of Blood Clots
- Treating the Menopause – the Concept of Risk and Benefit
- Early Menopause Due to Premature and Unexpected Ovarian Failure
- Menopause – Combined (Hormone Replacement Therapy)
- Diagnosing Menopause
- GP & HP Resources
- Menopausal HRT
- Anti-Mullerian Hormone test
- IMS: Decline in breast cancer
- Menopause - cardiology workshop calls for action
- Assessment and Management of Cardiovascular Risks in Women
- Risk of Osteoporosis
- WHI and Beyond: Controversies in HRT
- The AMS Practitioners Guidelines for Oestradiol (E2) Implants
- Libido and the Natural Menopause Transition
- Low Libido: the Psychological Aspect
- The menopausal transition as a risk factor for sleep apnea in women
- Biomedical Literature Databases
- Recommended Journals
- Rosiglitazone for postmenopausal women with Type 2 diabetes
- Sleep disturbance during the menopause
- NHMRC booklet for health professionals
- Resources
- Self Assessment Tools
- Studies published
- Weight gain and endometrial cancer
- Menopause and Diabetes Risk
- Testosterone spray and memory
- Flaxseed and hot flushes
- Gluten-free diets and menopause
- HRT and peripheral arterial disease
- Vasomotor symptoms and cardiovascular risk
- Health Outcomes After Stopping Conjugated Equine Estrogens Among Postmenopausal
- Hysterectomy and risk of cardiovascular disease: a population- based cohort study
- Herbs and Cognition
- Five year data on new SERM
- Alendronate vs raloxifine
- Osteoporosis Screening Tool
- Vaginal atrophy management
- Postmenopausal bleeding
- Dementia and HRT
- HRT and breast cancer mortality
- Vertebral fracture vigilance needed
- SSRIs and Tamoxifen
- Multivitamins and Breast Cancer Risk
- Menopause and Incontinence
- Zolendronic acid efficacy
- Risk of Atherosclerosis
- Symptoms in Midlife
- Intravaginal therapy alternative to HRT
- DHEA benefit for sexual disfunction
- HRT and Lung Cancer - 21 September 2009
- The benefits of berries for the heart
- Herbs no help for cognition:study
- Ovarian Cancer risk from HRT
- HRT and the new incidence of diabetes mellitus
- Tapering HT reduces symptom recurrence
- Improving Sexual Function
- It's not the soy, it's the reporting bias
- Age at Menopause Increasing in Europe
- Rise in Use of Unregistered Hormones
- The benefits of oestrogen following menopause: Why HRT should be offered to postmenopause women
- Breast Cancer after use of E + P in Postmenopausal Women NEJM 2009
- Testosterone patch and sex drive in women
- Androgen therapy for loss of desire in women
- Obesity, Abnormal 'Reward Circuitry' in Brain Linked by Imaging Studies
- Study indicates aspirin may not prevent heart attack, stroke in high-risk patients
- Hormone therapy and risk of myocardial infarction: a national register study
- LIFT Trial
- WISDOM Trial
- Video - Menopause: Evidence-based answers
- Members
- Media
- AMS Media Release: September 2011
- AMS Guide to Equivalent HRT Doses
- 2011 June 10 - HRT OK for most women: Updated Recommendations
- Media Archives
- 2010 Oct 18 - World Menopause Day
- 2009 October - World Menopause Day Information for women
- 2009 Jan 23 - Press Release Tibolone
- 2009 Jan 8 - HRT may be associated with reduced colorectal cancer risk.
- 2008 Nov 14 - Calcium, vitamin D do not lower breast-cancer risk
- 2008 Oct 18 - Women take heart – midlife, menopause and beyond
- 2008 Oct 6 - Hormone therapy and risk of myocardial infarction
- 2008 Aug 26 - LIFT Trial published
- 2008 Aug 22 - WISDOM Trial published
- 2008 Jun 11 - AMS response on HRT and Breast Cancer article
- 2008 Jan 15 - FDA Takes action against Compounded Menopause Hormone Therapy
- Media Kit
- Studies Recruiting
- Menopause and Exercise
- The effect of S-Equol on Hot Flushes in Menopausal Women
- Testosterone Cognition Study
- Metformin for the management of insulin resistance in overweight women at midlife
- Metformin for the management of insulin resistance in overweight women at midlife
- International Breast Cancer Intervention Study II